B8.064 Transgender Case Formative Question Stuff Flashcards
best way to prep transgender women for surgery
stop estrogen therapy
>estradiol can cause a hypercoagulable state
>spironolactone does NOT increase risk of VTE
what % of transgender people experience homelessness?
1/5 frequently due to: -fleeing intolerant family -being forced out by a family -losing a job due to discrimination -not being able to be employed due to discrimination and disability
which form of estrogen has the lowest risk of VTE
transdermal 17-beta estradiol
-bypassing hepatic metabolism results in more stable levels without high concentrations in the liver
-less pronounced effects on hepatic protein synthesis (CRP, markers of coagulation and fibrinolysis, steroid binding protein)
some studies show no increased risk with transdermal estrogen
finasteride
5a-reductase inhibitor
inhibits conversion of T to the more potent DHT
spironolactone
androgen blocker due to direct anti-androgen receptor activity
also a K+ sparing diuretic
most serious side effect of spironolactone
hyperkalemia
estrogen impact on lipid profile
LDL decreases
HDL increases
triglycerides increase
effect of estrogen therapy on bone
induces apoptosis in osteoclasts
inhibits apoptosis in osteoblasts
needed for proper closure epiphyseal growth plates in females and males
effects of estrogen deficiency on bone
increased cycles of remodeling and bone resorption leads to increased risk of osteoporosis
what to do if a transgender woman presents to the ER < 72 hr after sexual assault
empirically treat for chlamydia, gonorrhea, and trichomonas
why do transgender women have higher cardiovascular risk?
higher rates of tobaccos use, obesity, diabetes, and lipid disorders
reduced physical activity
what are transgender men more likely to experience than cisgender peers
suicide
41% of trans people attempt suicide at least once (5% of general pop)
aromatase
converts T to E
what should you do if a patient is a victim of IPV?
make sure the patient has an emergency plan
impact of ACA on transgender health care
prohibits most health insurers from discriminating based on transgender status
selection bias
nonrandom sampling or treatment allocation of subjects so that the study population is not representative of the target population
most commonly a sampling bias
function of PrEP with tenofovir disoproxil fumarate-emtricitabine (TDF-FTC)
acute HIV
risk of renal insufficiency
danazol
synthetic androgen that acts as a partial agonist at androgen receptors
letrazole
aromatase inhibitor, inhibits peripheral conversion of androgens to estrogen
most common side effect of masculinizing hormone therapy
polycythemia
monitor Hct and keep below 50%
greatest risks of feminizing therapy
VTE events (like stroke)
best options for pregnancy prevention in transgender men
long acting reversible contraception
T use not reliable to prevent ovulation
OCPs not good bc they contain estrogen
options other than spironolactone for androgen blockade
GnRH analog > downregulates GnRH receptor in pituitary causing a decrease in FSH/LH
mesonephric duct
forms male genital structures
paramesonephric duct
forms female genital structures